Literature DB >> 23791471

Regulatory science in Europe: the case of schizophrenia trials.

Corrado Barbui1, Irene Bighelli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23791471     DOI: 10.1016/S0140-6736(13)60255-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Mapping actions to improve access to medicines for mental disorders in low and middle income countries.

Authors:  C Barbui; T Dua; K Kolappa; B Saraceno; S Saxena
Journal:  Epidemiol Psychiatr Sci       Date:  2017-01-09       Impact factor: 6.892

2.  New EMA report on paliperidone 3-month injections: taking clinical and policy decisions without an adequate evidence base.

Authors:  G Ostuzzi; D Papola; C Gastaldon; C Barbui
Journal:  Epidemiol Psychiatr Sci       Date:  2016-12-22       Impact factor: 6.892

3.  Public health psychopharmacology: a new research discipline comes of age?

Authors:  C Barbui; G Ostuzzi; B Godman
Journal:  Epidemiol Psychiatr Sci       Date:  2018-02       Impact factor: 6.892

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.